Key Takeaways
- GlobalData (DATA) shares rallied 3.70% to 98.2 GBX, featuring among top UK stock gainers, on relative volume of around 1.16 times normal activity.
- The likely catalysts are the group's March 2026 graduation to the LSE Main Market, full-year results showing 13% headline revenue growth, and continued strategic backing from Inflexion.
- GlobalData is a UK-based data, analytics and intelligence platform serving multiple industries through recurring, subscription-based revenue.
- With a market cap of about 701.66M GBP, a P/E near 22.68, EPS of roughly 0.04 GBP and EPS growth of around +16, the shares carry a premium, growth-oriented rating.
- Bullish factors include the Main Market listing, recurring revenue, sector tailwinds and strategic private-equity validation.
- Key risks include the premium valuation, margin compression from investment, modest underlying growth and integration and competition risk.
- Investors are watching underlying revenue growth, margin recovery, the benefits of the Main Market listing and further M&A activity.
Introduction
GlobalData plc (LSE:DATA) appeared in a TradingView snapshot of the top gaining UK stocks, with the shares rallying 3.70% to 98.2 GBX in the latest session. As one of the larger names on that list, GlobalData offers a useful case study in how a data and analytics business can attract renewed investor attention. Trading volume of 1.53 million shares accompanied the move, equating to a relative volume reading of 1.16, modestly above the stock's typical activity. That is a less dramatic liquidity surge than some smaller UK market movers exhibit, which suggests the gain may be underpinned by broad interest rather than a single thin-volume spike.
On size, GlobalData carries a market capitalisation of around 701.66 million GBP, positioning it among mid-cap UK stocks rather than the speculative small-cap end of the market. The shares trade on a trailing P/E of approximately 22.68, a premium multiple consistent with a recurring-revenue analytics platform. Diluted EPS over the trailing twelve months is roughly 0.04 GBP, with reported EPS growth of around +16, pointing to a business still expanding its earnings base at a healthy double-digit rate.
This article looks at why GlobalData shares may have climbed, what the company does, how the stock data reads, and which catalysts and risks investors appear to be tracking. For anyone asking why did DATA stock rise today, the answer most likely lies in a combination of a recent listing milestone, solid results and the broader appetite for high-quality data businesses in the UK stock market today.
Why the Stock Moved
The most significant recent development for GlobalData has been its move from AIM to the Main Market of the London Stock Exchange, which took effect in early March 2026. A step up to the Main Market is a notable milestone for any company. It can broaden the potential shareholder base, since some institutional investors and index funds are restricted to Main Market securities, and it is often read as a signal of corporate maturity and confidence. A graduation of this kind can support sentiment for an extended period as the market reassesses the stock's eligibility for inclusion in broader indices and mandates, which may help explain why DATA has featured among top UK stock gainers.
Alongside the listing move, GlobalData reported full-year results for the period to 31 December 2025. Total revenue grew 13% to about £322.1m, helped by acquisitions, while underlying revenue growth was more modest at around 1%. Adjusted EBITDA came in at roughly £110.2m, down on the prior year as the group invested in its cost base and integrated recent M&A, with the adjusted EBITDA margin at about 34%. Management also pointed to growth in contracted forward revenue, providing visibility into 2026. A set of results showing double-digit headline revenue growth and improving forward visibility, even with margin pressure from investment, can be enough to keep a quality data name well bid.
Strategic backing is a further part of the narrative. GlobalData's growth journey has been catalysed in part by Inflexion Private Equity's acquisition of a 40% minority stake in the group's Healthcare business, which provided strategic support and financial flexibility for continued investment. Private-equity involvement of this kind is often interpreted positively by the market, as it can validate the value of underlying assets and fund expansion. Taken together, the Main Market debut, the results and the strategic partnership form a credible backdrop to the 3.70% gain. That said, with relative volume only modestly above normal at 1.16, the move appears measured rather than frenzied, and part of it may simply reflect positive sector sentiment toward data and analytics businesses.
Company Overview
GlobalData plc is a data, analytics and intelligence company headquartered in the United Kingdom. Following its March 2026 graduation, the shares trade on the Main Market of the London Stock Exchange. The business sits within the broader data services and business-information sector, an area that has attracted strong investor interest in recent years thanks to its recurring-revenue characteristics and the growing corporate appetite for proprietary data and analytics.
At its core, GlobalData provides subscription-based access to data, insights and analysis across many industries. Its platform aggregates proprietary data sets, market intelligence, forecasts and expert analysis, which clients use to inform strategy, identify opportunities and benchmark performance. The company serves sectors spanning healthcare, consumer, technology, financial services and energy, giving it a diversified end-market profile and lending resilience to revenue through economic cycles.
A defining feature of the business model is its emphasis on recurring, contracted revenue. Subscription and renewal-based income provides visibility and stickiness, since clients embedded in a data platform tend to renew rather than switch. GlobalData has also pursued a deliberate strategy of acquisitions to broaden its data assets and capabilities, supplementing organic growth, and has invested in integrating artificial intelligence into its products. That combination of recurring revenue, diversified end markets and a buy-and-build approach is central to how the market values the company, and helps explain the premium rating relative to many other UK stocks.
Stock Data Analysis
Examining the snapshot data, GlobalData's 3.70% rise to 98.2 GBX was accompanied by turnover of 1.53 million shares. The relative volume of 1.16 indicates trading was somewhat above average but not exceptional, which is a meaningful distinction. Where a small-cap might see relative volume spike to several times normal on a single piece of news, GlobalData's more contained reading is consistent with a mid-cap stock attracting steady, broad-based interest. That profile tends to make moves more durable than the sharp, liquidity-driven spikes seen in thinner names.
Valuation is where GlobalData differs most clearly from typical UK small-cap stocks. The trailing P/E of around 22.68 is a premium multiple, reflecting the market's willingness to pay up for recurring revenue, high margins and growth potential. Investors effectively price in continued expansion of contracted revenue and the benefits of the group's investment and acquisition programme. Diluted EPS of roughly 0.04 GBP over the trailing twelve months, paired with EPS growth of about +16, supports that premium by showing the earnings base is still compounding at a double-digit pace.
The market capitalisation of around 701.66 million GBP places GlobalData firmly in mid-cap territory among LSE stocks. At this size, it is more likely to attract institutional coverage than the smaller AIM stocks lower down the gainers list, and the recent Main Market listing strengthens that accessibility. For investors comparing UK market movers, GlobalData's move is supported by scale, a recurring-revenue model and a defensible market position, even if its premium rating leaves less room for error than a cheaper name.
Bullish Factors
Several elements could be viewed as supportive of the investment case. The Main Market listing is foremost among them. By broadening the investor base and improving index eligibility, the graduation may attract incremental institutional demand over time, and it signals management confidence in the group's prospects. For a business that spent years on AIM, this is a logical next step that can re-rate the shares as the market adjusts to its new status.
The underlying business model is a second positive. Recurring, contracted revenue across a diversified set of industries provides visibility and resilience, and the reported growth in contracted forward revenue offers some assurance about the 2026 outlook. Data and analytics is a structurally growing sector, and GlobalData's investment in artificial intelligence and product development positions it to benefit from rising corporate demand for proprietary insight. Double-digit headline revenue growth and EPS growth of around +16 underline that the business is still expanding.
Strategic validation rounds out the bullish case. Inflexion's minority stake in the Healthcare business provides both financial firepower and a vote of confidence in the value of GlobalData's assets. The group's track record of acquisitions, integrated with organic growth, gives it multiple levers to compound revenue and earnings. For investors seeking exposure to a high-quality data platform among FTSE stocks and broader UK stocks, these attributes help explain why GlobalData periodically features among the top UK stock gainers.
Bearish Risks
The risks deserve equal weight. The most obvious is valuation. A trailing P/E of around 22.68 prices in continued growth, which means any disappointment in revenue, margins or contracted forward revenue could prompt a sharp de-rating. Premium-rated stocks are more vulnerable to sentiment shifts, and a setback in the data sector or the wider UK stock market today could weigh on the shares disproportionately.
Margin pressure is a specific near-term concern. Adjusted EBITDA fell in the latest year as the group invested in its cost base and absorbed the integration of recent acquisitions, and the adjusted EBITDA margin compressed to around 34%. While management frames this as investment for future growth, the market will want evidence that margins recover and that the spending translates into accelerating underlying revenue, which grew only about 1% on an underlying basis in the period. Until that is clear, profitability remains a watch item.
Integration and execution risk also apply. A buy-and-build strategy depends on successfully absorbing acquisitions and realising synergies, and missteps can dilute returns. The presence of a significant private-equity stake, while supportive, introduces questions around future ownership intentions and potential overhangs. More broadly, GlobalData faces competition from other data and intelligence providers, and any loss of pricing power or client churn would undermine the recurring-revenue thesis. As with all UK market movers, a single strong session does not eliminate these longer-term considerations.
What Investors Are Watching Next
Looking forward, the clearest signposts are the trajectory of underlying revenue growth and the recovery of margins. Investors will scrutinise upcoming trading updates and interim results for evidence that the group's investment programme is translating into accelerating organic growth and that adjusted EBITDA margins are stabilising or improving. Confirmation that contracted forward revenue continues to build would reinforce confidence in the 2026 and 2027 outlook.
The benefits of the Main Market listing will also be closely watched. Market participants will look for signs of incremental institutional ownership, potential index inclusion and improved liquidity now that the shares trade on the Main Market. On the strategic front, the evolution of the Inflexion relationship and any further acquisitions will shape the growth narrative, while progress on artificial-intelligence integration across the product suite could become an increasingly important differentiator. Finally, given the premium rating, investors will remain sensitive to any commentary on pricing, client retention and competitive dynamics. The interplay of these factors will determine whether GlobalData shares can sustain the momentum that placed them among the top UK stock gainers.






Please wait processing your request...